Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells

G. I. Johnston, A. Kurosky, R. P. McEver

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

GMP-140 is an integral membrane glycoprotein of apparent M(r) = 140,000 located in secretory storage granules of platelets and vascular endothelial cells. When these cells are activated, GMP-140 redistributes from the membrane of the granules to the plasma membrane. To gain insight into the potential function of GMP-140, we examined aspects of its structure and biosynthesis. The amino acid composition of platelet GMP-140 revealed elevated numbers of cystinyl (6.1%), prolinyl (7.2%), and tryptophanyl (2.1%) residues. GMP-140 contained 28.8% carbohydrate by weight, distributed among N-acetylneuraminic acid, neutral sugar, and N-acetylglucosamine residues. Enzymatic removal of N-linked oligosaccharides reduced the protein's apparent M(r) by more than 50,000. The biosynthesis of GMP-140 in HEL cells, which share biochemical features with megakaryocytes, was studied by pulse-chase labeling with [35S]cysteine followed by immunoprecipitation. HEL cells synthesized a heterogeneous GMP-140 precursor of 98-125 kDa which converted to a mature 140-kDa form within 40-60 min. Removal of high mannose oligosaccharides by endo-β-N-acetylglucosaminidase H treatment reduced the apparent M(r) of the precursor but not the mature protein. Tunicamycin-treated HEL cells synthesized three to four precursors of 80-92 kDa, suggesting the possibility of heterogeneity of GMP-140 at the protein level. Exposure of activated platelets to proteases followed by Western blotting indicated that most of the mass of GMP-140 was located on the extracytoplasmic side of the membrane. Our studies indicate that GMP-140 is a cysteine-rich, heavily glycosylated protein with a large extracytoplasmic domain. These features are compatible with a receptor function for the molecule when it is exposed on the surface of activated platelets and endothelial cells.

Original languageEnglish (US)
Pages (from-to)1816-1823
Number of pages8
JournalJournal of Biological Chemistry
Volume264
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

P-Selectin
Endothelial cells
Platelets
Membrane Proteins
Blood Platelets
Endothelial Cells
Biosynthesis
Oligosaccharides
Cysteine
Proteins
Membranes
Tunicamycin
Acetylglucosaminidase
Megakaryocytes
Acetylglucosamine
Membrane Glycoproteins
Secretory Vesicles
N-Acetylneuraminic Acid
Cell membranes
Mannose

ASJC Scopus subject areas

  • Biochemistry

Cite this

Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells. / Johnston, G. I.; Kurosky, A.; McEver, R. P.

In: Journal of Biological Chemistry, Vol. 264, No. 3, 1989, p. 1816-1823.

Research output: Contribution to journalArticle

@article{4f551a86b44640bba09f0dbac79ee63f,
title = "Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells",
abstract = "GMP-140 is an integral membrane glycoprotein of apparent M(r) = 140,000 located in secretory storage granules of platelets and vascular endothelial cells. When these cells are activated, GMP-140 redistributes from the membrane of the granules to the plasma membrane. To gain insight into the potential function of GMP-140, we examined aspects of its structure and biosynthesis. The amino acid composition of platelet GMP-140 revealed elevated numbers of cystinyl (6.1{\%}), prolinyl (7.2{\%}), and tryptophanyl (2.1{\%}) residues. GMP-140 contained 28.8{\%} carbohydrate by weight, distributed among N-acetylneuraminic acid, neutral sugar, and N-acetylglucosamine residues. Enzymatic removal of N-linked oligosaccharides reduced the protein's apparent M(r) by more than 50,000. The biosynthesis of GMP-140 in HEL cells, which share biochemical features with megakaryocytes, was studied by pulse-chase labeling with [35S]cysteine followed by immunoprecipitation. HEL cells synthesized a heterogeneous GMP-140 precursor of 98-125 kDa which converted to a mature 140-kDa form within 40-60 min. Removal of high mannose oligosaccharides by endo-β-N-acetylglucosaminidase H treatment reduced the apparent M(r) of the precursor but not the mature protein. Tunicamycin-treated HEL cells synthesized three to four precursors of 80-92 kDa, suggesting the possibility of heterogeneity of GMP-140 at the protein level. Exposure of activated platelets to proteases followed by Western blotting indicated that most of the mass of GMP-140 was located on the extracytoplasmic side of the membrane. Our studies indicate that GMP-140 is a cysteine-rich, heavily glycosylated protein with a large extracytoplasmic domain. These features are compatible with a receptor function for the molecule when it is exposed on the surface of activated platelets and endothelial cells.",
author = "Johnston, {G. I.} and A. Kurosky and McEver, {R. P.}",
year = "1989",
language = "English (US)",
volume = "264",
pages = "1816--1823",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "3",

}

TY - JOUR

T1 - Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells

AU - Johnston, G. I.

AU - Kurosky, A.

AU - McEver, R. P.

PY - 1989

Y1 - 1989

N2 - GMP-140 is an integral membrane glycoprotein of apparent M(r) = 140,000 located in secretory storage granules of platelets and vascular endothelial cells. When these cells are activated, GMP-140 redistributes from the membrane of the granules to the plasma membrane. To gain insight into the potential function of GMP-140, we examined aspects of its structure and biosynthesis. The amino acid composition of platelet GMP-140 revealed elevated numbers of cystinyl (6.1%), prolinyl (7.2%), and tryptophanyl (2.1%) residues. GMP-140 contained 28.8% carbohydrate by weight, distributed among N-acetylneuraminic acid, neutral sugar, and N-acetylglucosamine residues. Enzymatic removal of N-linked oligosaccharides reduced the protein's apparent M(r) by more than 50,000. The biosynthesis of GMP-140 in HEL cells, which share biochemical features with megakaryocytes, was studied by pulse-chase labeling with [35S]cysteine followed by immunoprecipitation. HEL cells synthesized a heterogeneous GMP-140 precursor of 98-125 kDa which converted to a mature 140-kDa form within 40-60 min. Removal of high mannose oligosaccharides by endo-β-N-acetylglucosaminidase H treatment reduced the apparent M(r) of the precursor but not the mature protein. Tunicamycin-treated HEL cells synthesized three to four precursors of 80-92 kDa, suggesting the possibility of heterogeneity of GMP-140 at the protein level. Exposure of activated platelets to proteases followed by Western blotting indicated that most of the mass of GMP-140 was located on the extracytoplasmic side of the membrane. Our studies indicate that GMP-140 is a cysteine-rich, heavily glycosylated protein with a large extracytoplasmic domain. These features are compatible with a receptor function for the molecule when it is exposed on the surface of activated platelets and endothelial cells.

AB - GMP-140 is an integral membrane glycoprotein of apparent M(r) = 140,000 located in secretory storage granules of platelets and vascular endothelial cells. When these cells are activated, GMP-140 redistributes from the membrane of the granules to the plasma membrane. To gain insight into the potential function of GMP-140, we examined aspects of its structure and biosynthesis. The amino acid composition of platelet GMP-140 revealed elevated numbers of cystinyl (6.1%), prolinyl (7.2%), and tryptophanyl (2.1%) residues. GMP-140 contained 28.8% carbohydrate by weight, distributed among N-acetylneuraminic acid, neutral sugar, and N-acetylglucosamine residues. Enzymatic removal of N-linked oligosaccharides reduced the protein's apparent M(r) by more than 50,000. The biosynthesis of GMP-140 in HEL cells, which share biochemical features with megakaryocytes, was studied by pulse-chase labeling with [35S]cysteine followed by immunoprecipitation. HEL cells synthesized a heterogeneous GMP-140 precursor of 98-125 kDa which converted to a mature 140-kDa form within 40-60 min. Removal of high mannose oligosaccharides by endo-β-N-acetylglucosaminidase H treatment reduced the apparent M(r) of the precursor but not the mature protein. Tunicamycin-treated HEL cells synthesized three to four precursors of 80-92 kDa, suggesting the possibility of heterogeneity of GMP-140 at the protein level. Exposure of activated platelets to proteases followed by Western blotting indicated that most of the mass of GMP-140 was located on the extracytoplasmic side of the membrane. Our studies indicate that GMP-140 is a cysteine-rich, heavily glycosylated protein with a large extracytoplasmic domain. These features are compatible with a receptor function for the molecule when it is exposed on the surface of activated platelets and endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=0024496315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024496315&partnerID=8YFLogxK

M3 - Article

C2 - 2463989

AN - SCOPUS:0024496315

VL - 264

SP - 1816

EP - 1823

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 3

ER -